BSX
Price
$97.02
Change
-$2.21 (-2.23%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
143.81B
76 days until earnings call
Intraday BUY SELL Signals
PEN
Price
$283.15
Change
+$5.05 (+1.82%)
Updated
Nov 19 closing price
Capitalization
11.09B
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BSX vs PEN

Header iconBSX vs PEN Comparison
Open Charts BSX vs PENBanner chart's image
Boston Scientific
Price$97.02
Change-$2.21 (-2.23%)
Volume$81.44K
Capitalization143.81B
Penumbra
Price$283.15
Change+$5.05 (+1.82%)
Volume$576.9K
Capitalization11.09B
BSX vs PEN Comparison Chart in %
BSX
Daily Signal:
Gain/Loss:
PEN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BSX vs. PEN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and PEN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BSX: $97.01 vs. PEN: $283.15)
Brand notoriety: BSX: Notable vs. PEN: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BSX: 162% vs. PEN: 140%
Market capitalization -- BSX: $143.81B vs. PEN: $11.09B
BSX [@Medical/Nursing Services] is valued at $143.81B. PEN’s [@Medical/Nursing Services] market capitalization is $11.09B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $219.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • PEN’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than PEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while PEN’s TA Score has 6 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 5 bearish.
  • PEN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PEN is a better buy in the short-term than BSX.

Price Growth

BSX (@Medical/Nursing Services) experienced а -6.84% price change this week, while PEN (@Medical/Nursing Services) price change was +1.02% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.47%. For the same industry, the average monthly price growth was -8.60%, and the average quarterly price growth was +8.79%.

Reported Earning Dates

BSX is expected to report earnings on Feb 04, 2026.

PEN is expected to report earnings on Feb 24, 2026.

Industries' Descriptions

@Medical/Nursing Services (-5.47% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($144B) has a higher market cap than PEN($11.1B). PEN has higher P/E ratio than BSX: PEN (67.58) vs BSX (51.88). PEN YTD gains are higher at: 19.231 vs. BSX (8.609). BSX has higher annual earnings (EBITDA): 4.65B vs. PEN (194M). BSX has more cash in the bank: 534M vs. PEN (425M). PEN has less debt than BSX: PEN (221M) vs BSX (12B). BSX has higher revenues than PEN: BSX (18.5B) vs PEN (1.28B).
BSXPENBSX / PEN
Capitalization144B11.1B1,297%
EBITDA4.65B194M2,395%
Gain YTD8.60919.23145%
P/E Ratio51.8867.5877%
Revenue18.5B1.28B1,445%
Total Cash534M425M126%
Total Debt12B221M5,430%
FUNDAMENTALS RATINGS
BSX vs PEN: Fundamental Ratings
BSX
PEN
OUTLOOK RATING
1..100
1814
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
680
SMR RATING
1..100
6261
PRICE GROWTH RATING
1..100
5346
P/E GROWTH RATING
1..100
7899
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSX's Valuation (79) in the Medical Specialties industry is in the same range as PEN (81). This means that BSX’s stock grew similarly to PEN’s over the last 12 months.

BSX's Profit vs Risk Rating (6) in the Medical Specialties industry is significantly better than the same rating for PEN (80). This means that BSX’s stock grew significantly faster than PEN’s over the last 12 months.

PEN's SMR Rating (61) in the Medical Specialties industry is in the same range as BSX (62). This means that PEN’s stock grew similarly to BSX’s over the last 12 months.

PEN's Price Growth Rating (46) in the Medical Specialties industry is in the same range as BSX (53). This means that PEN’s stock grew similarly to BSX’s over the last 12 months.

BSX's P/E Growth Rating (78) in the Medical Specialties industry is in the same range as PEN (99). This means that BSX’s stock grew similarly to PEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXPEN
RSI
ODDS (%)
Bearish Trend 2 days ago
33%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
62%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signal:
Gain/Loss:
PEN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DPST79.852.32
+2.99%
Direxion Daily Regional Bnks Bull 3X ETF
DMAX26.580.06
+0.21%
iShares Large Cap Max Buffer Dec ETF
FNDX26.20-0.05
-0.19%
Schwab Fundamental U.S. Large CompanyETF
PGHY19.87-0.04
-0.20%
Invesco Glb ex-US High Yld Corp Bd ETF
SMHB3.55-0.11
-2.90%
ETRACS 2xMnthly Py Lvrgd US SmCpHiDivETN

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-2.23%
ISRG - BSX
71%
Closely correlated
+3.27%
SYK - BSX
65%
Loosely correlated
+1.31%
MMSI - BSX
56%
Loosely correlated
-0.57%
EW - BSX
51%
Loosely correlated
+2.36%
ALC - BSX
49%
Loosely correlated
-0.48%
More